Trump signs executive order to speed up U.S. rocket launches
The U.S. government on Wednesday signed an executive order to ease federal regulations on commercial rocket launches, potentially benefiting SpaceX an...
China has achieved a significant medical milestone, with its drug regulator announcing the approval of the country's first domestically developed 9-valent human papillomavirus (HPV) vaccine.
In a landmark development for public health, China's drug regulator has given the green light to the nation's first domestically developed 9-valent human papillomavirus (HPV) vaccine. The approval, announced Wednesday, marks a significant turning point, ending over a decade of foreign companies dominating the lucrative and critical HPV vaccine market within the country.
The newly approved vaccine is designed to target nine distinct strains of the human papillomavirus, making it only the second vaccine of its kind globally to offer such broad protection. HPV vaccines are widely recognised as crucial tools in preventing cervical cancer in women and genital cancers and warts in both men and women.
Human Papillomavirus (HPV) is a very common virus, primarily spread through close physical intimacy, with many types. While some types can cause warts, certain "high-risk" types are responsible for nearly all cases of cervical cancer, as well as other cancers in both men and women. Vaccination is a key method of prevention.
This approval represents a major stride in China's push for self-sufficiency in key pharmaceutical and healthcare sectors. It is expected to significantly bolster the country's vaccination efforts, potentially improving accessibility and affordability of this vital preventative measure for millions of Chinese citizens. The domestic production could also reduce reliance on international supply chains, ensuring more stable access to the vaccine.
Experts believe that the introduction of a homegrown 9-valent HPV vaccine will not only address a significant public health need but also stimulate further innovation within China's biopharmaceutical industry. This development is poised to have a profound impact on public health outcomes across China, offering robust protection against HPV-related diseases.
The world’s biggest dance music festival faces an unexpected setback as a fire destroys its main stage, prompting a last-minute response from organisers determined to keep the party alive in Boom, Belgium.
A powerful eruption at Japan’s Shinmoedake volcano sent an ash plume more than 3,000 metres high on Sunday morning, prompting safety warnings from authorities.
According to the German Research Centre for Geosciences (GFZ), a magnitude 5.7 earthquake struck the Oaxaca region of Mexico on Saturday.
A resumption of Iraq’s Kurdish oil exports is not expected in the near term, sources familiar with the matter said on Friday, despite an announcement by Iraq’s federal government a day earlier stating that shipments would resume immediately.
A magnitude 5.2 earthquake struck 56 kilometres east of Gorgan in northern Iran early Sunday morning, according to preliminary seismic data.
A scientist in the US revealed the pioneering device which works alongside artificial intelligence to monitor the body's vital signs and alert in case of danger.
Dubai has launched its first-ever 'Mallathon,' a month-long event turning shopping centres into indoor running tracks to offer residents a safe way to exercise during peak summer heat, that started 1 August.
Tech giant Google has announced a $1 billion investment to support Artificial Intelligence (AI) education and research at universities across the United States.
What shapes human nature? Why do some people act with compassion while others turn cruel? For centuries, thinkers — from philosophers and playwrights to theologians and psychologists — have grappled with these timeless questions, searching for what lies at the heart of good and evil.
A new skin cancer drug has been developed using a genetically engineered virus that targets and replicates only cancer cells. That's according to public broadcaster NHK who said that researchers in Japan found that 77.8% of those tested, improved.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment